Predictors of outcome in Cryptococcus neoformans var. gattii meningitis
|
|
- Britton Phillips
- 6 years ago
- Views:
Transcription
1 Q J Med 1996; 89: Predictors of outcome in Cryptococcus neoformans var. gattii meningitis R.A. SEATON 1 ' 2, S. NARAQI 2, J.P. WEMBRI 2 and D.A. WARRELL 1 From f/ie 1 Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, UK, and 2 The Department of Clinical Sciences, Medical Faculty, University of Papua New Guinea, Papua New Guinea Received 14 December 1995 and in revised form 12 February 1996 Summary In Papua New Guinea, Cryptococcus neoformans var. gattii meningitis has a high fatality rate even in immunocompetent patients. Our retrospective study attempted to identify marker of poor prognosis. Of 88 immunocompetent patients, 30 (34.1%) died, usually soon after admission, and mortality was higher in men (p = 0.025) and older patients (p= 0.039). Death was associated with altered consciousness ( p < 0.001), a history of convulsions prior to treatment (p = 0.002) and a maximum systolic blood pressure of >150 mmhg (p = 0.017). These data suggest that death results from raised intracranial pressure and subsequent tentorial herniation. However, CSF opening pressure measured on admission was raised in 29/36 (81 %) patients and did not predict outcome. In survivors, relapse was uncommon and was not predicted by discharge serum cryptococcal antigen titres, which were frequently raised on completion of therapy in asymptomatic patients. Mortality may be reduced if efforts are made to lower intracranial pressure in those patients who present with markers of poor prognosis. Introduction Cryptococcus neoformans is an encapsulated fungus which causes a life-threatening meningo-encephalitis. Two varieties of this organism are recognized, var. neoformans and var. gattii. The variety neoformans, which has been well studied, occurs worldwide 1 and usually causes disease in immunosuppressed individuals, 2 " 4 particularly patients with HIV infection. 5 In contrast, var. gattii infection occurs predominantly in immunocompetent individuals 6 " 8 living in tropical or sub-tropical regions. 1 In the Central province of Papua New Guinea (PNG), cryptococcal meningitis is the commonest type of chronic meningitis with an estimated annual incidence of 42.8 cases/million population. The majority of patients have no underlying immunosuppressive state, and are infected with the variety gattii. In PNG, the in-hospital case fatality rate in immunocompetent patients has been reported as 22.4%, with an overall case fatality rate of 40.8%. Patients are frequently disabled with blindness, which occurs in 31% of survivors. 9 These data contrast with other published studies in immunocompetent patients which have reported a much lower fatality rate with few or no visual complications. 6 ' 7 To improve our understanding of the pathogenesis of this infection and so potentially to improve patient management, this study investigated those demographic, clinical and laboratory variables which might predict a poor outcome in immunocompetent patients. Our investigation into those factors associated with visual loss have been reported elsewhere. 10 ' 11 Methods The study was based in the Port Moresby General Hospital (PMGH), a 600-bed university teaching Address correspondence to Dr R.A. Seaton, Infection and Immunodeficiency Unit, King's Cross Hospital, Clepington Road, Dundee DD3 8EA Oxford University Press 1996
2 424 R.A. Seaton etal. hospital in the nation's capital. Retrospective data were collected from the casenotes of patients admitted to the Port Moresby General hospital between 1979 and December 1992 and nationwide prospective data were collected from January 1993 to September using x 2 statistics or Fisher's exact test (two-tailed). Relative risks (RR) and 95% CIs for death were calculated. Continuous data were compared using the Wilcoxon two-sample test or student t-test as appropriate. Calculated p values of <0.05 were considered significant. Diagnosis Diagnosis of cryptococcal meningitis was based on a history of chronic headache and vomiting with the finding of budding yeasts on India-ink-stained cerebrospinal fluid (CSF), cryptococcal antigen titres in the CSF or serum >1 :32, or a positive culture of CSF on Sabouraud's media. The variety type was determined by subculturing colonies on canavinine glycine-bromothymol blue (CGBB) agar; var. gattii gives the medium a characteristic cobalt blue colour. 12 Biotyped cases were confirmed serologically by the Australian mycology reference laboratory in Adelaide. Inclusion and exclusion criteria Patients whose cultures were confirmed as var neoformans, and those who had underlying immunosuppression including HIV infection were excluded. Only patients whose outcomes were known were included. Patients who absconded from hospital during their treatment course were excluded. Data collection Clinical and laboratory data were recorded along with CSF findings in a proportion of patients who underwent lumbar puncture. CSF pressure was categorized as 'raised' if the opening pressure exceeded 200 mm of CSF. Cryptococcal antigen concentration was measured in both CSF and serum by a latex agglutination method (Crypto-LA, Carter Wallace). The majority of sera were heat- and proteaseinactivated prior to testing. Anti-cryptococcal therapy All patients received standard anticryptococcal therapy with parenteral amphotericin B (0.3-1 mg/ kg/day) and oral flucytosine (150 mg/kg/day in divided doses) for more than 4 weeks, except those who died shortly after admission. Data storage and statistical analysis All data were recorded on standardized proformas and stored and analysed on the EPI-info 5 statistical software package. The proportion of patients who died was calculated for a series of clinical and laboratory variables and results were compared by Results A total of 88 patients met the stated inclusion criteria. Of the 49 patients previously reported between 1979 and November 1990, 9 37 had sufficient information in the case notes to merit inclusion. From November 1990 to January 1993, a further 12 patients were identified from case records. Prospective studies began in January 1993, continuing until September 1995, and a total of 60 patients were identified nationwide, of whom 39 met the inclusion criteria. The reasons for exclusion were lack of clinical data (13), absconding early in the treatment course (2), HIV infection diagnosis (4) and C. neoformans var. neoformans infection (2). Thirty-nine patients had CSF cultured, and all were positive for C. neoformans. Of the twentyseven CSF isolates biotyped on CGBB agar, all were confirmed as var. gattii. Consecutive CSF isolates biotyped during the prospective study period revealed 18/19 (95%) isolates in immunocompetent patients to be of the variety gattii. A total of 30 (34.1%) patients died during their hospital admission. Variables examined for an association with a poor outcome are given in Tables 1 and 2. The fatality rate was significantly higher in male patients (p = 0.025) and those who died were older on admission (p = 0.039). The time that symptoms of meningitis had been present prior to admission was similar in the two groups and did not predict outcome (p = 0.956). However, those patients who presented with a history of convulsions were significantly more likely to die (p = 0.002). Of the clinical signs on admission, only an altered level of consciousness (ranging from confusion to obtundation and coma) predicted an outcome of death (p<0.001). A maximum blood pressure reading of >150mmHg at any time during admission was also significantly associated with death, but other signs such as papilloedema, abducens nerve palsy and CSF opening pressure of greater than 200 mm/csf were not. No associations were found between death and other CSF findings, including cryptococcal antigen titres. However, patients who died tended to have higher serum cryptococcal antigen titres. Patients who died did not survive long after admission. The median time from admission to death was 8 days (range days), and the mean dose
3 Predicting outcome in gattii meningitis 425 Table 1 Clinical and demographic variables on admission examined for an association with an outcome of death Died (n = 30) Survived (n = 58) RR (95% Cl) P Male sex Urban residence Age (years) Symptoms (weeks) Altered consciousness Convulsions Papilloedema Maximum systolic BP >150mmHg Cranial nerve palsy on admission Abducens palsy Other neurological signs 25/30 (83.3%) 12/25 (48%) 30(15-55) 5 (1-17) 27/30 (90%) 13/27 (48.1%) 19/28 (67.9%) 8/23 (34.8%) 7/27 (25.9%) 2/27 (7.4%) 5/30 (16.7%) 33/58 (56.9%) 34/57 (59.6%) 24 (7-46) 4 (1-20) 15/58 (25.9%) 8/57 (14%) 43/53 (81.1%) 4/40 (10%) 18/57 (31.6%) 12/57 (21.1%) 4/58 (6.9%) 2.59 ( ) 0.72 ( ) 9.86 ( ) 2.79 ( ) 0.65 ( ) 2.44 ( ) 0.83 ( ) 0.4 ( ) 1.76 ( ) < For continuous data, median values are shown with the range given in brackets. For categorical data, proportions are followed by percentages in brackets. RR (95% Cl), relative risk (95% confidence interval). Table 2 Investigation results on admission examined for an association with an outcome of death Died (n = 30) Survived (n = 58) RR (95% Cl) CSF opening pressure ^200 mm of CSF CSF India ink stain positive Serum cryptococcal antigen titre CSF cryptococcal antigen titre Total CSF white cell count per mm 3 CSF protein (g/l) CSF glucose (mmol/l) 7/10(70%) 22/26(84.6%) 0.56( ) 17/19(89.5%) 33/35(94.3%) 0.68( ) 1 :4096 (-1 :262144) 1 :2048 (1 :32-1 :65536) 1 :2048 (-16384) 31.5 (0-714) 0.83 ( ) 2.5 ( ) 1 :2048 ( ) 91 (0-1434) 0.84 ( ) 1.9 ( ) For continuous data, median values are shown with the range given in brackets. For categorical data, proportions are followed by percentages in brackets. RR (95% Cl), relative risk (95% confidence interval). of amphotericin B received was g (SD 0.462). In contrast, survivors were treated for a median time of 10.5 weeks (4-52 weeks) and received a mean dose of 1.6 g (SD 0.92) amphotericin B. The mean follow-up for survivors was 15 months (range months). Modes of death In all but two of the patients in whom the mode of death was documented, death occurred following coma and cardiorespiratory arrest. This was associated with raised systolic blood pressure in eight (Table 1). Death did not appear to be precipitated by lumbar puncture, which was performed in 64 patients. In one patient, death occurred following a cardiorespiratory arrest late in the treatment course, and followed an infusion of amphotericin B. In a further patient, treatment was complicated by jaundice and acute renal failure. Only one autopsy was performed, and this demonstrated widespread meningo-encephalitis with small cerebral abscesses. Sequelae of infection in survivors Of the 58 patients who survived, six later relapsed and one died on the second admission. Three patients required long-term treatment with anticonvulsants following cure of meningitis, one who had convulsions prior to treatment and two who developed convulsions during therapy. Visual loss and hearing loss were common sequelae. Visual loss was documented in 30/57 (52.6%) of survivors and 21/57 (36.8%) were blind. A full description of the patterns of visual loss and the value of corticosteroid treatment in preventing visual deterioration is given else-
4 426 R.A. Seaton etal. where. 10 ' 11 Pure tone audiometry was performed in 35 survivors, of whom 22 (62.9%) were documented to have some degree of sensorineural hearing loss. Two patients who survived were blind with severe bilateral sensorineural deafness. Cryptococcal antigen titres and CSF findings in survivors In twelve patients followed prospectively (eight of whom were confirmed to have infection with var. gattii), serum cryptococcal antigen titres were measured before and on completion of anticryptococcal therapy as well as at follow up (Table 3). By completion of therapy, all patients were asymptomatic having received curative doses of amphotericin B. In 11/12 patients, serum cryptococcal antigen titres fell during treatment although in 10/12 titres were >1 :32 on discharge. Despite these high discharge titres patients remained asymptomatic and in 9/12 further falls in titres occurred despite receiving no further anticryptococcal therapy. Of 15 patients in whom India ink examination was carried out before and after treatment, nine (60%) had persistence of encapsulated C. neoformans although cultures were negative, and none relapsed. Discussion This study has attempted to identify those features of Cryptococcus neoformans var. gattii meningitis on admission which will predict a poor outcome. Although it is possible that not all our patients were infected with var. gattii, 95% of CSF isolates in the prospectively studied immunocompetent patient were confirmed as this variety. We have no reason to suspect that prior to 1993 the proportion of var. gattii isolates in immunocompetent patients was any different. The likelihood of inclusion of var. neoformans has been further reduced by excluding all patients who had evidence of underlying immunosuppressive disorders. We have confirmed earlier reports that this disease has a high mortality (34.1%) as well as a high rate of serious sequelae in survivors. In Australia, deaths due to var. gattii meningitis are less common, occurring in 0/20 patients in one series 7 and 4/26 (15.4%) in a second series. 6 In non-immunosuppressed patients in Brazil, however, where var. gattii accounts for 58.3% of infections, the mortality rate of 38.6% was comparable to that in our series. 8 In our investigation for poor prognostic signs we identified a number of associations. A significantly higher proportion of men died, and those patients who died tended to be older than the survivors. Altered consciousness and a history of convulsions were strongly predictive of death, as was a maximum systolic blood pressure >150mmHg. Altered consciousness has previously been identified as an important adverse prognostic sign in AIDS-related cryptococcal meningitis 13 as well as in predominantly healthy patients with cryptococcal meningitis in Singapore. 14 Altered consciousness, convulsions and raised systolic blood pressure may reflect raised intracranial pressure and subsequent tentorial herniation. However, CSF opening pressure, measured by lumbar puncture on admission, was frequently raised in both those who died and those who survived, and was therefore not a good predictor of outcome. It has recently been shown that CSF opening pressure is not significantly associated with an outcome of visual loss in PNG. 10 In PNG, neuroradiological scans are not available, but elsewhere cerebral CT scan abnormalities have Table 3 Serum cryptococcal antigen titres following cessation of therapy Patient Cryptococcal antigen titres in sera Pre-treatment Immediate post-treatment Follow-up Months from discharge Total dose of amphotericin B (g) :8192 1:1024 1:8192 1:8192 1:1024 1:512 1:32 1:4 1 :64 1 :16 1 :64 1 :64 1 :16 1 :4 1:8 0 1:
5 Predicting outcome in gattii meningitis 427 been commonly observed in immunocompetent patients with cryptococcal meningitis. Mass lesions, hydrocephalus, oedema and other cerebral abnormalities have been documented in 57-69% of var. gattii cases in Australia 6 ' 7 and in Brazil 55% of immunocompetent patients had cerebral CT abnormalities. 8 In Australia, neurosurgical procedures are frequently done, and this probably accounts for the lower mortality there observed. 6 ' 7 CSF findings on admission were not significantly different between the two outcome groups, although those who died tended to have higher serum cryptococcal antigen titres and lower white-cell counts in the CSF. Diamond and Bennett identified high CSF opening pressure, low glucose concentrations, low CSF leucocyte counts, as well as high cryptococcal antigen titres in the CSF and serum, as associated with a poor outcome. 15 The more marked differences in CSF findings in this American series perhaps reflect the high proportion of immunosuppressed patients who fail to mount a good immune response to infection. These differences may also reflect the variety type, with Americans infected predominantly with the variety neoformans. In AIDS-related cryptococcal meningitis, high CSF cryptococcal antigen titres were also predictive of death. 13 Survivors were followed up for a median time of 15 months, and relapse occurred infrequently, in 6/58 (10%) patients. Despite relapse, five of these patients were successfully treated. In Australia, 20% of patients with gattii relapsed. 6 In HIV-infected patients with cryptococcal meningitis, relapse occurs in up to 50% of patients who complete therapy and are culture-negative, 16 and maintenance therapy is usually required. Relapse in HIV infected patients has been shown to be a true recrudescence 17 due to subclinical foci of infection. We did not find discharge cryptococcal antigen titres to be a useful predictor of relapse. In the twelve patients in whom serial serum cryptococcal antigen titres were measured, high discharge titres continued to decline in the majority despite no further treatment being given. This probably reflects dead, non-viable antigen agglutinating with the test reagent, or a lower load of antigen which can be managed by these immunocompetent patients. Likewise, examination of CSF on completion of treatment frequently showed persistence of encapsulated organisms with negative culture results. We did not document a significant rise in titre of antigen in any patient which might be more indicative of relapse as has been observed in HIV-antibody-positive patients. 18 These data help to better understand the pathophysiology of C. neoformans var gattii meningitis. It is suggested that the high mortality observed in this series results from the untreated effects of raised intracranial pressure. If survival is to be improved, we suggest more aggressive measures be undertaken to lower intracranial pressure in patients who present with an altered state of consciousness, convulsions or raised systolic blood pressure. Prospective studies of outcome in patients with poor prognostic signs treated with aggressive measures to lower intracranial pressure should help to confirm or refute these preliminary observations. Acknowledgements Andrew Seaton was funded by the Colt Foundation, UK. We are grateful to Professor Isi Kevau and Drs Barnabus Mavo, Adolf Saweri, James Amini, Ben Miam, Jo Amban, David Lalloo and Ian Laurenson, who gave permission to include their patients in this series. Mrs Trixie Wain-Marjen and Mr Paul Kila performed the cryptococcal antigen tests, and Dr David Ellis of the Australian mycology reference laboratory, Adelaide kindly performed confirmatory testing of the CSF isolates. Thanks also to Professor A. Seaton for critical reading of the manuscript. References 1. Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 1984; 120: Collins VP, Gelhorn A, Trimble JR. Coincidence of cryptococcosis and disease of reticuloendothelial and lymphatic systems. Cancer 1951; 4: Schroter GPJ, Temple DR, Husberg BS, Weil R, Starzl TE. Cryptococcosis after renal transplantation: Report of ten cases. Surgery1976; 79(3): Kaplan MH, Rosen PP, Armstrong D. Cryptococcosis in a cancer hospital. Cancer 1977; 39: Kovacs JA, Kovas AA, Polis M, Wright C, Gill VJ, Tuazon CU, Gelmann EP, Lane HC, Longfield R, Overturf G, Macher AM, Fauci AS, Parrillo JE, Bennett JE, Masur H. Cryptococcosis in the Acquired Immunodeficiency Syndrome. Ann Intern Med. 1985; 103: Mitchell DH, Sorrell TC, Allworth AM, Heath CH, McGregor AR, Papanaoum, Richards MJ, Gottlieb T. Cryptococcal disease of the CNS in Immunocompetent Hosts: Influence of Cryptococcal variety on Clinical Manifestations and Outcome. Clin Infect Dis 1995; 20: Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis 1995; 21: Rozenbaum R, GoncalvesJR. Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis 1994; 18: Lalloo D, Fisher D, Naraqi S, Laurenson I, Temu P, Sinha A, Saweri A, Mavo B. Cryptococcal meningitis (C. neoformans var. gattii) leading to blindness in previously healthy Melanesian adults in Papua New Guinea. QJ Med 1994; 87: Seaton RA, Verma N, Naraqi S, Wembri J. Ocular
6 428 R.A. Seaton et al. manifestations of Cryptococcus neoformans var. gattii meningitis in immunocompetent patients. 1. Predictors of visual loss (submitted). 11. Seaton RA, Verma N, Naraqi S, Wembri J. Ocular manifestations of cryptococcal meningitis in immunocompetent patients. 2. Effect of corticosteroids (submitted). 12. Kwon-Chung KJ, Polacheck I, Bennet JE. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol 1982; 15: Saag MS, Powderly WC, Cloud GA, Robinson P, Crieco MH, Sharkey PK, Thompson SE, Sugar AM, Tuazon CU, Fisher JF, Hyslop N, Jacobson JM, Hafner R, Graybill JR, Dismukes WE, and the NIAD mycoses study group and the AIDS clinical trials group. Comparison of amphotericin B with fluconazole in the treatment of acute AIDs associated cryptococcal meningitis. N Engl J Med 1992; 326: Tjia TL, Yeow YK, Tan CB. Cryptococcal meningitis. J Neurol Neurosurg Psychiatr 1985; 48: Diamond RD, Bennett JE. Prognostic factors in cryptococcal meningitis. Ann Intern Med 1974; 80: Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ. Cryptococcal disease in patients with the Acquired Immunodeficiency syndrome. Ann Intern Med 1986; 104: Spitzer ED, Spitzer SG, Freundlich LF, Casadevall A. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Z.anceM993; 341: Powderly WG, Cloud GA, Dismukes WE, Saag MS. Measurement of cryptococcal antigen in serum and cerebrospinal fluid: Value in the management of AIDSassociated cryptococcal meningitis. Clin Infect Dis 1994; 18:
Cryptococcal Meningitis
Cryptococcal Meningitis Dr N Thumbiran Infectious Diseases Department UKZN Index patient 27 year old female Presented to King Edward Hospital on 17/07/2005 with: Severe headaches Vomiting Photophobia X
More informationTe-Yu Lin, Kuo-Ming Yeh, Jung-Chung Lin, Ning-Chi Wang, Ming-Yieh Peng, Feng-Yee Chang
J Microbiol Immunol Infect. 9;:-6 Cryptococcal disease in patients with or without human immunodeficiency virus: clinical presentation and monitoring of serum cryptococcal antigen titers Te-Yu Lin, Kuo-Ming
More informationKAP conference 19 th March 2008: Dr Mohamed Hussein Jin.
SENSITIVITY PATTERNS, SEROTYPES OF CRYPTOCOCCUS NEOFORMANS AND DIAGNOSTIC VALUE OF INDIA INK IN PATIENTS WITH CRYPTOCOCCAL MENINGITIS AT KENYATTA NATIONAL HOSPITAL. KAP conference 19 th March 2008: Dr
More informationComparison of Clinical Features and Survival between Cryptococcosis in Human Immunodeficiency Virus (HIV)-Positive and HIV-Negative Patients
Jpn. J. Infect. Dis., 61, 111-115, 2008 Original Article Comparison of Clinical Features and Survival between Cryptococcosis in Human Immunodeficiency Virus (HIV)-Positive and HIV-Negative Patients Ubonvan
More informationManagement of Cryptococcal Meningitis in HIV-infected children in National Pediatric Hospital
Management of Cryptococcal Meningitis in HIV-infected children in National Pediatric Hospital Olivier Marcy 1,2, Sam Sophan 2, Ung Vibol 2, Chan Bunthy 2, Pok Moroun 2, Chy Kam Hoy 2, Ban Thy 2, Chhour
More informationCryptococcal Meningitis: Looking beyond HIV
International Journal of Scientific and Research Publications, Volume 3, Issue 3, March 2013 1 Cryptococcal Meningitis: Looking beyond HIV Deepak Nayak M *. Sushma V. Belurkar **, Chethan Manohar ***,
More informationAetiology of meningitis at the Moi Teaching and Referral Hospital, Eldoret, Kenya. D. K. Lagat, MBChB, Mmed(Moi)
Aetiology of meningitis at the Moi Teaching and Referral Hospital, Eldoret, Kenya D. K. Lagat, MBChB, Mmed(Moi) Introduction Meningitis is common and important Syndromes of meningitis: Acute bacterial
More informationCryptococcosis of the Central Nervous System: Classical and Immune-Reconstitution Disease
Cryptococcosis of the Central Nervous System: Classical and Immune-Reconstitution Disease Assist Prof. Somnuek Sungkanuparph Division of Infectious Diseases Faculty of Medicine Ramathibodi Hospital Mahidol
More informationCryptococcus gattii Fungal Meningitis. By Cassy Hedberg BI 234
Cryptococcus gattii Fungal Meningitis By Cassy Hedberg BI 234 This disease s deadliest weapon is the fact you ve never heard of it -Kausik Datta, Post-doctoral Fellow at Johns Hopkins Medicine A deadly
More informationAcute Encephalitis in Children at Port Moresby General Hospital:
Acute Encephalitis in Children at Port Moresby General Hospital: The role of Japanese encephalitis virus and assessing the quality of care DR K KIROMAT MMED 2017 INTRODUCTION Japanese encephalitis (JE)
More informationFungal Meningitis. Stefan Zimmerli Institute for infectious diseases University of Bern Friedbühlstrasse Bern
Fungal Meningitis Stefan Zimmerli Institute for infectious diseases University of Bern Friedbühlstrasse 51 3010 Bern Death due to infectious diseases in sub-saharan Africa Park BJ. Et al AIDS 2009;23:525
More informationChallenges in Management of Cryptococcal Meningitis. Yunus Moosa Department of ID NRMSM Durban
Challenges in Management of Cryptococcal Meningitis Yunus Moosa Department of ID NRMSM Durban Overview Epidemiology Pathogenesis Clinical presentation Diagnosis Prognostic factors Antifungal Treatment
More informationISPUB.COM. Cryptococcal Meningitis in AIDS. O Busari, A Adeyemi, S Agboola INTRODUCTION BIOLOGY AND PATHOGENESIS CLINICAL FEATURES
ISPUB.COM The Internet Journal of Infectious Diseases Volume 7 Number 1 O Busari, A Adeyemi, S Agboola Citation O Busari, A Adeyemi, S Agboola.. The Internet Journal of Infectious Diseases. 2008 Volume
More informationFungal Meningitis in an Immunocompetent Patient
Clin Drug Investig (2013) 33 (Suppl 1):S47 S50 DOI 10.1007/s40261-012-0021-5 CASE REPORT Fungal Meningitis in an Immunocompetent Patient Ricardo Louro Rui Ferreira Catarina Pinheiro Helena Parada Domitília
More informationCRYPTOCOCCOSIS IN HIV-INFECTED CHILDREN
CRYPTOCOCCOSIS IN HIV-INFECTED CHILDREN Surachai Likasitwattanakul, Boonsom Poneprasert and Virat Sirisanthana Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Scarborough M, Gordon SB, Whitty CJM, et al. Corticosteroids
More informationGUIDELINE FOR THE MANAGEMENT OF CRYPTOCOCCAL MENINGITIS
GUIDELINE FOR THE MANAGEMENT OF CRYPTOCOCCAL MENINGITIS Full title of guideline Guideline for the management of cryptococcal meningitis Author Dr P Venkatesan (ID consultant) Division and specialty Medicine,
More informationCryptococcosis*,** *usually considered to be an opportunistic mycosis that often becomes systemic.
Cryptococcosis*,** Definition - a chronic, subacute or rarely acute pulmonary, systemic or meningitic infection caused by Cryptococcus neoformans - the encapsulated Blastomycetes anamorph of Filobasidiella
More informationGeneral History. 林陳 珠 Female 69 years old 住院期間 : ~ Chief Complaint : sudden loss of conscious 5 minutes in the morning.
General History 林陳 珠 Female 69 years old 住院期間 : 93.5.8~93.5.15 Chief Complaint : sudden loss of conscious for 2-52 5 minutes in the morning. General History DM under regular medical control for 10 years.
More informationCase Report Diagnosis of Cryptococcosis and Prevention of Cryptococcal Meningitis Using a Novel Point-of-Care Lateral Flow Assay
Case Reports in Medicine Volume 2013, Article ID 640216, 4 pages http://dx.doi.org/10.1155/2013/640216 Case Report Diagnosis of Cryptococcosis and Prevention of Cryptococcal Meningitis Using a Novel Point-of-Care
More informationCRYPTOCOCCUS MENINGITIS IN A COHORT OF HIV POSITIVE KENYAN PATIENTS: OUTCOME AFTER TWO WEEKS OF THERAPY
December 2013 (Supplement) Ea s t Af r i c a n Me d i c a l Jo u r n a l S33 East African Medical Journal Vol. 90 No. 12 (Supplement) December 2013 CRYPTOCOCCUS MENINGITIS IN A COHORT OF HIV POSITIVE KENYAN
More informationJudith A. Aberg, MD; Linda M. Mundy, MD; and William G. Powderly, MD
Pulmonary Cryptococcosis in Patients Without HIV Infection* Judith A. Aberg, MD; Linda M. Mundy, MD; and William G. Powderly, MD Purpose: To further elucidate the diagnostic and therapeutic approaches
More informationCryptococcal. meningitis
274 PRACTICAL NEUROLOGY REVIEW Cryptococcal meningitis Pract Neurol: first published as 10.1111/j.1474-7766.2004.00254.x on 1 October 2004. Downloaded from http://pn.bmj.com/ Jeremy N Day Clinical Research
More informationNeurosciences- Lecture 2 Virus associated meningitis Polio Virus
Al- Balqa Applied University Faculty of Medicine Neurosciences- Lecture 2 Virus associated meningitis Polio Virus Dr. Hala Al Daghistani The most important Enteroviruses are the three poliovirus serotypes
More informationRichard Malik Centre for Veterinary Education The University of Sydney
Richard Malik Centre for Veterinary Education The University of Sydney 1 Pathology Update 3/8/2019 Pathology Update 3/8/2019 2 Pathology Update 3/8/2019 3 Pathology Update 3/8/2019 4 Pathology Update 3/8/2019
More informationPREVALENCE OF CRYPTOCOCCAL MENINGITIS AMONGST HIV SEROPOSITIVE CASES FROM A TERTIARY CARE HOSPITAL
IJCRR Vol 06 issue 14 Section: Healthcare Category: Research Received on: 25/05/14 Revised on: 21/06/14 Accepted on: 12/07/14 PREVALENCE OF CRYPTOCOCCAL MENINGITIS AMONGST HIV SEROPOSITIVE CASES FROM A
More informationRAPIDLY PROGRESSIVE PULMONARY CRYPTOCOCCOSIS WITH CAVITATION IN AN IMMUNOCOMPETENT WOMAN: A CASE REPORT AND LITERATURE REVIEW
RAPIDLY PROGRESSIVE PULMONARY CRYPTOCOCCOSIS WITH CAVITATION IN AN IMMUNOCOMPETENT WOMAN: A CASE REPORT AND LITERATURE REVIEW Junyan Qu, Xiaohui Wang, Yanbin Liu and Xiaoju Lv Center of Infectious Disease,
More informationToo Competent for Cryptococcus Starr Steinhilber, MD Victoria Johnson, MD
SGIM Clinical Vignettes Session F May 12, 2012 Too Competent for Cryptococcus Starr Steinhilber, MD Victoria Johnson, MD 48 yo healthy AAM Sx Fevers Chills Headache Back pain Vomiting Headache Back pain
More information14-ID-07. Standardized Surveillance Case Definition for Cryptococcus gattii infection
14-ID-07 Committee: Infectious Disease Title: tandardized urveillance Case Definition for Cryptococcus gattii infection I. tatement of the Problem Cryptococcal infections are caused by the environmentally
More informationCryptococcal Meningitis in Patients with or without Human Immunodeficiency Virus: Experience in a Tertiary Hospital
Original Article DOI 10.3349/ymj.2011.52.3.482 pissn: 0513-5796, eissn: 1976-2437 Yonsei Med J 52(3):482-487, 2011 Cryptococcal Meningitis in Patients with or without Human Immunodeficiency Virus: Experience
More informationDr Paul Holmes Guy s and St Thomas NHS Foundation Trust, London
Dr Paul Holmes Guy s and St Thomas NHS Foundation Trust, London HIV and Lumbar punctures in 2018 Paul Holmes Consultant Neurologist Guy s and St Thomas Hospitals I have no competing interests Summary of
More informationdevelop capsules when released from the basidia. Budding may begin after encapsulation, thereby completing the life cycle.
INTRODUCTION Cryptococcosis is an invasive fungal infection due to Cryptococcus neoformans which has become increasingly prevalent in immunocompromised patients. The microbiology and epidemiology of Cryptococcus
More informationCryptococcal Antigen Latex Agglutination Test
Cryptococcal Antigen Latex Agglutination Test Cat. No.:DLAT1109 Pkg.Size:100T Intended use The Cryptococcal Antigen Latex Agglutination Test is a simple and rapid latex agglutination test for the qualitative
More informationComparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection
Journal of Microbiology, Immunology and Infection (2011) 44, 338e345 available at www.sciencedirect.com journal homepage: www.e-jmii.com ORIGINAL ARTICLE Comparisons of clinical features and mortality
More informationPrognostic indicators of childhood acute viral encephalitis
ecommons@aku Community Health Sciences Department of Community Health Sciences December 1999 Prognostic indicators of childhood acute viral encephalitis E Bhutto Aga Khan University M Naim Aga Khan University
More informationCase Presentation. Intern Tutor VS 2007/01/26
Case Presentation Intern 8931150 Tutor VS 2007/01/26 About The Patient 38 years old worker ID: M120794700 Admission date: 2006/12/28 C.C.: Fever with headache for 2 days Present Illness Smoker, alcoholism
More informationOpportunistic infections in the era of cart, still a problem in resource-limited settings
Opportunistic infections in the era of cart, still a problem in resource-limited settings Cristiana Oprea Victor Babes Clinical Hospital for Infectious and Tropical Diseases, Bucharest, Romania Assessment
More informationPerformance of Cryptococcus Antigen Latex Agglutination Kits on
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 1991, p. 333-339 95-1137/91/2333-7$2./ Copyright C) 1991, American Society for Microbiology Vol. 29, No. 2 Performance of Cryptococcus Antigen Latex Agglutination
More informationTreatment of Acute Hydrocephalus After Subarachnoid Hemorrhage With Serial Lumbar Puncture
19 Treatment of Acute After Subarachnoid Hemorrhage With Serial Lumbar Puncture Djo Hasan, MD; Kenneth W. Lindsay, PhD, FRCS; and Marinus Vermeulen, MD Downloaded from http://ahajournals.org by on vember,
More informationThis PDF is available for free download from a site hosted by Medknow Publications. (www.medknow.com).
Review Article Cryptococcal meningitis: Clinical, diagnostic and therapeutic overviews P. Satishchandra, T. Mathew, G. Gadre, S. Nagarathna, A. Chandramukhi*, A. Mahadevan**, S. K. Shankar** Department
More informationCerebral Toxoplasmosis in HIV-Infected Patients. Ahmed Saad,MD,FACP
Cerebral Toxoplasmosis in HIV-Infected Patients Ahmed Saad,MD,FACP Introduction Toxoplasmosis: Caused by the intracellular protozoan, Toxoplasma gondii. Immunocompetent persons with primary infection
More informationCNS Infections in the Pediatric Age Group
CNS Infections in the Pediatric Age Group Introduction CNS infections are frequently life-threatening In the Philippines, bacterial meningitis is one of the top leading causes of mortality in children
More informationApproach to the critically ill patient with advanced HIV in low resource settings. Sebastian Albus, MD MSF, Operational Center Bruxelles
Approach to the critically ill patient with advanced HIV in low resource settings Sebastian Albus, MD MSF, Operational Center Bruxelles why You should be this guy. instead of that guy ME USFR, Guinea-Conakry
More informationGAFFI Fact Sheet. Cryptococcal meningitis. Introduction
GAFFI Fact Sheet Cryptococcal meningitis ION NS ACT ALOR ECTIO B GLOND F L INF FU NGA FU Introduction DARKER AREAS AND TEXT FIT WITHIN CIRCLE Cryptococcal meningitis is caused by one of the two closely
More informationEvaluation of Predictive CD4 Count and Clinical Reliability in Detecting Cryptococcus neoformans at Kenyatta National Hospital, Kenya
Journal of Agriculture, Pure and Applied Science and Technology ISSN 2073-8749 Printed by Moi University Press 2009 J. agric. pure appl. sci. technol. www.japast.scriptmania.com Evaluation of Predictive
More informationCASE REPORT. Abstract. Introduction. Case Report
CASE REPORT Disseminated Cryptococcosis Complicated with Bilateral Pleural Effusion and Ascites during Corticosteroid Therapy for Organizing Pneumonia with Myelodysplastic Syndrome Hiroyuki Kamiya 1, Rie
More informationCommon Fungi. Catherine Diamond MD MPH
Common Fungi Catherine Diamond MD MPH Birth Month and Day & Last Four Digits of Your Cell Phone # BEFORE: http://tinyurl.com/kvfy3ts AFTER: http://tinyurl.com/lc4dzwr Clinically Common Fungi Yeast Mold
More informationOpportunistic Infections BHIVA Guidelines
Opportunistic Infections BHIVA Guidelines Mark Nelson David Dockrell Simon Edwards I have.. 1. Read all of the BHIVA guidelines 12% 2. Read some of the BHIVA guidelines in their entirety 3. Browsed some
More informationCNS Infections. Philip Gothard Consultant in Infectious Diseases Hospital for Tropical Diseases, London. Hammersmith Acute Medicine 2011
CNS Infections Philip Gothard Consultant in Infectious Diseases Hospital for Tropical Diseases, London Hammersmith Acute Medicine 2011 Case 1 HISTORY 27y man Unwell 3 days Fever Headache Photophobia Previously
More informationClinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
IDSA GUIDELINES Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America John R. Perfect, 1 William E. Dismukes, 2 Francoise Dromer,
More informationMay He Rest in Peace
May He Rest in Peace Neurologic Complications of AIDS Medical Knowledge Fiesta 2012 Paul K. King MD pkingmd@yahoo.com Objectives definition of HIV/AIDS what are the neurologic complications of AIDS how
More informationmycoses Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates from AIDS patients in Kenya Summary Introduction
mycoses Diagnosis,Therapy and Prophylaxis of Fungal Diseases Original article Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates from AIDS patients in Kenya Rennatus Mdodo,
More informationOpen Access RESEARCH ARTICLE. Research article
RESEARCH ARTICLE Open Access Research article A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in
More informationOriginal Article. Noparat Oniem, M.D., Somnuek Sungkanuparph, M.D.
Original Article Vol. 29 No. 1 Primary prophylaxis for cryptococcosis with fluconazole:- Oniem N & Sungkanuparph S. 5 Primary prophylaxis for cryptococcosis with fluconazole among HIV-infected patients
More informationEffect of Severity of Meningitis on Fungicidal Activity of Flucytosine Combined with Fluconazole in a Murine Model of Cryptococcal Meningitis
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 1997, p. 1589 1593 Vol. 41, No. 7 0066-4804/97/$04.00 0 Copyright 1997, American Society for Microbiology Effect of Severity of Meningitis on Fungicidal Activity
More informationMeningi&s in HIV NORTHWEST AIDS EDUCATION AND TRAINING CENTER
NORTHWEST AIDS EDUCATION AND TRAINING CENTER Meningi&s in HIV Christina M. Marra, MD Neurology and Medicine University of Washington School of Medicine Susceptibility to CNS Opportunistic Infections CD4+
More informationA Child with Cross Eye. Nia Kurniati
A Child with Cross Eye Nia Kurniati Background When dealing with new case with potential social problem, complication related to ARV treatment may pose difficulties Restricted resource to address potential
More informationORIGINAL ARTICLE STUDY OF CRYPTOCOCCAL MENINGITIS IN HIV POSITIVE PATIENTS
STUDY OF CRYPTOCOCCAL MENINGITIS IN HIV POSITIVE PATIENTS Sunil Kumar 1, Madhu Jumla. 1. Assistant Professor, Department of Medicine, Vijayanagara Institute of Medical Sciences, Bellary, Karnataka.. Assistant
More informationDENGUE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT
DENGUE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT Usa Thisyakorn and Chule Thisyakorn Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Abstract. Dengue has spread
More informationManagement of Severe Traumatic Brain Injury
Guideline for North Bristol Trust Management of Severe Traumatic Brain Injury This guideline describes the following: Initial assessment and management of the patient with head injury Indications for CT
More informationWhen the drugs don t work- a case of HSV encephalitis.
When the drugs don t work- a case of HSV encephalitis. Nicky Price Consultant Virologist Public Health Wales 67 year old Caucasian Female Presenting complaint 2 day history of: Confusion Shivering Headache
More informationEpilepsy after two different neurosurgical approaches
Journal ofneurology, Neurosurgery, and Psychiatry, 1976, 39, 1052-1056 Epilepsy after two different neurosurgical approaches to the treatment of ruptured intracranial aneurysm R. J. CABRAL, T. T. KING,
More informationECMM Excellence Centers Quality Audit
ECMM Excellence Centers Quality Audit Person in charge: Department: Head of Department: Laboratory is accredited according to ISO 15189 (Medical Laboratories Requirements for quality and competence) Inspected
More information5-Fluorocytosine resistance in clinical isolates of cryptococcus neoformans
Med. J. Malaysia Vol. 44 No. 3 September 1989 5-Fluorocytosine resistance in clinical isolates of cryptococcus neoformans C.S. Chin, B Se (Hons) Y.M. Cheong, MBBS, M Se Bacteriology Division Institute
More informationIDIOPATHIC INTRACRANIAL HYPERTENSION
IDIOPATHIC INTRACRANIAL HYPERTENSION ASSESSMENT OF VISUAL FUNCTION AND PROGNOSIS FOR VISUAL OUTCOME Doctor of Philosophy thesis Anglia Ruskin University, Cambridge Fiona J. Rowe Department of Orthoptics,
More informationPractice Guidelines for the Management of Cryptococcal Disease
Subscription Information for 710 Practice Guidelines for the Management of Cryptococcal Disease Michael S. Saag, 1 Richard J. Graybill, 2 Robert A. Larsen, 3 Peter G. Pappas, 1 John R. Perfect, 4 William
More informationAnti-Cryptococcal-Globulin-Latex Production for Rapid Detection of Cryptococcus neoformans Polysaccharide Antigen in Cryptococcosis
Iranian J Publ Health, 2005, Vol. 34, No. 4, pp.15-23 Anti-Cryptococcal-Globulin-Latex Production for Rapid Detection of Cryptococcus neoformans Polysaccharide Antigen in Cryptococcosis *F Zaini, M Safara,
More informationManagement of cryptococcal meningitis in HIVinfected patients: Experience from western India
Original Article Management of cryptococcal meningitis in HIVinfected patients: Experience from western India Atul K. Patel, Ketan K. Patel, Rajiv Ranjan, Shalin Shah 2, Jagdish K. Patel 1 Infectious Diseases
More informationAppendix I (a) Human Surveillance Case Definition (Revised July 4, 2005)
Section A: Case Definitions Appendix I (a) Human Surveillance Case Definition (Revised July 4, 2005) The current Case Definitions were drafted with available information at the time of writing. Case Definitions
More informationANTIBIOTIC GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED MENINGITIS AND ENCEPHALITIS IN ADULTS
ANTIBIOTIC GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED MENINGITIS AND ENCEPHALITIS IN ADULTS Version 4.0 Date ratified February 2009 Review date February 2011 Ratified by Authors Consultation Evidence
More informationInfected Ventriculoperitoneal Shunt Due to Cryptococcus neoformans: the Case Report
CASE REPORT Vol. 31 No. 3 Infected ventriculoperitoneal shunt due to Cryptococcus neoformans:- Dhissayakamol O & Suankratay C. 181 Infected Ventriculoperitoneal Shunt Due to Cryptococcus neoformans: the
More informationTREATMENT OF CRYPTOCOCCAL MENINGITIS ASSOCIATED WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME
TREATMENT OF CRYPTOCOCCAL MENINGITIS ASSOCIATED WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME CHARLES M. VAN DER HORST, M.D., MICHAEL S. SAAG, M.D., GRETCHEN A. CLOUD, M.S., RICHARD J. HAMILL, M.D., J. RICHARD
More informationA retrospective review of paediatric. cryptococcosis in three academic. hospitals in Johannesburg,
A retrospective review of paediatric cryptococcosis in three academic hospitals in Johannesburg, 2002-2011. Fikile Cynthia Mabena A dissertation submitted to the Faculty of Health Sciences, University
More informationScottish Surveillance of Healthcare Associated Infection Programme (SSHAIP) Health Protection Scotland (HPS) SSI Surveillance Protocol 7th Edition
1 Contents Female reproductive system operations (Abdominal hysterectomy and Caesarean section)... 3 Intra-abdominal infections... 3 Endometritis... 4 Other infections of the female reproductive tract...
More informationClinical Utility of the Cryptococcal Antigen Lateral Flow Assay in a Diagnostic Mycology Laboratory
Clinical Utility of the Cryptococcal Antigen Lateral Flow Assay in a Diagnostic Mycology Laboratory Brendan J. McMullan 1,2 *., Catriona Halliday 1., Tania C. Sorrell 3,4, David Judd 1, Sue Sleiman 1,
More informationORIGINAL ARTICLE /j x
ORIGINAL ARTICLE 10.1111/j.1469-0691.2006.01367.x Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated
More informationOutcome of Severe Malaria in Endemic Zone - Study From a District Hospital of Bangladesh
Dr. Md. AMIR HOSSAIN Department of Medicine Rangamati General Hospital Deputed to BSMMU, Dhaka. Outcome of Severe Malaria in Endemic Zone - Study From a District Hospital of Bangladesh 1 INTRODUCTION In
More informationWest Nile Virus in Maricopa County
West Nile Virus in Maricopa County A Culex quinquefasciatus mosquito on a human finger. Image by James Gathany/ CDC gov/ public domain Maricopa County Department of Public Health Office of Epidemiology
More informationOriginal Articles O 2 ).
Original Articles Cryptococcal meningitis in HIV infected patients a retrospective study of S.Marcos Hospital experience from 998 to Cristina Ângela, Dina Leal, Alexandre Carvalho, Narciso Oliveira, Teresa
More informationTitle. individual. Author(s) Medical Mycology, 46(4), pp Issue Date Right
NAOSITE: Nagasaki University's Ac Title Author(s) Citation Reversible visual disturbance due t individual. Nakamura, Shigeki; Izumikawa, Koich Kyoko; Mishima, Kazuaki; Kakeya, Hi Yanagihara, Katsunori;
More informationUnusual Presentation of Central Nervous System Cryptococcal Infection in an Immunocompetent Patient
AJNR Am J Neuroradiol 26:2522 2526, November/December 2005 Case Report Unusual Presentation of Central Nervous System Cryptococcal Infection in an Immunocompetent Patient Gaurav Saigal, M. Judith Donovan
More informationEfficacy of Amphotericin B in a Fat Emulsion for the Treatment of Cryptococcal Meningitis in AIDS Patients
BJID 2007; 11 (April) 203 Efficacy of Amphotericin B in a Fat Emulsion for the Treatment of Cryptococcal Meningitis in AIDS Patients Fernando Góngora Rubio 1, Jeferson Rodrigo Zanon 2, Margarete Teresa
More informationWest Nile Virus in Maricopa County
West Nile Virus in Maricopa County Maricopa County Department of Public Health Office of Epidemiology July 21 January 1, 29 December 31, 29 Commentary West Nile virus (WNV) is a mosquito-borne virus that
More informationLumbar puncture. Invasive procedure: diagnostic or therapeutic. The subarachnoid space 4-13 ys: ml Replenished: 4-6 h Routine LP (3-5 ml): <1h
Lumbar puncture Lumbar puncture Invasive procedure: diagnostic or therapeutic. The subarachnoid space 4-13 ys: 65-150ml Replenished: 4-6 h Routine LP (3-5 ml):
More informationand the Working Group from the EMBO-AIDS Related Mycoses Workshop Institute of Infectious Disease and Molecular Medicine, University of Cape Town,
1 AIDS-related mycoses: the way forward Gordon D. Brown 1,2*, Graeme Meintjes 1, Jay K. Kolls 3, Clive Gray 1, William Horsnell 1 and the Working Group from the EMBO-AIDS Related Mycoses Workshop 1 Institute
More informationWest Nile Virus in Maricopa County
West Nile Virus in Maricopa County Maricopa County Department of Public Health Office of Epidemiology July 2009 January 1, 2008 December 31, 2008 Commentary West Nile virus (WNV) is a mosquito-borne virus
More informationVentriculoperitoneal shunts in non-hiv cryptococcal meningitis
Liu et al. BMC Neurology (2018) 18:58 https://doi.org/10.1186/s12883-018-1053-0 RESEARCH ARTICLE Open Access Ventriculoperitoneal shunts in non-hiv cryptococcal meningitis Jia Liu 1, Zhuo-lin Chen 1, Min
More informationEpidemiology and Laboratory Diagnosis of Fungal Diseases
Medical Mycology (BIOL 4849) Summer 2007 Dr. Cooper Epidemiology of Mycoses Epidemiology and Laboratory Diagnosis of Fungal Diseases Mycosis (pl., mycoses) - an infection caused by a fungus Two broad categories
More informationCongenital CMV infection. Infectious and Tropical Pediatric Division Department of Child Health Medical Faculty, University of Sumatera Utara
Congenital CMV infection Infectious and Tropical Pediatric Division Department of Child Health Medical Faculty, University of Sumatera Utara Congenital CMV infection Approximately 0.15 2% of live births
More informationJunyan Qu, Taoyou Zhou, Cejun Zhong, Rong Deng and Xiaoju Lü *
Qu et al. BMC Infectious Diseases (2017) 17:51 DOI 10.1186/s12879-016-2126-6 RESEARCH ARTICLE Open Access Comparison of clinical features and prognostic factors in HIV-negative adults with cryptococcal
More informationAlberta Health Public Health Notifiable Disease Management Guidelines December Subacute Sclerosing Panencephalitis (SSPE)
December 2015 Subacute Sclerosing Panencephalitis (SSPE) Revision Dates Case Definition Reporting Requirements Remainder of the Guideline (i.e., Etiology to References sections inclusive) Case Definition
More informationMANAGEMENT OF SUSPECTED VIRAL ENCEPHALITIS IN CHILDREN
MANAGEMENT OF SUSPECTED VIRAL ENCEPHALITIS IN CHILDREN OVERVIEW 1980s: dramatically improved by aciclovir HSV encephalitis in adults Delays treatment(> 48h after hospital admission): associated with a
More informationPrevalence of cryptococcosis among HIV-infected patients in Yaounde, Cameroon
Prevalence of cryptococcosis among HIV-infected patients in Yaounde, Cameroon * Dzoyem JP 1, Kechia FA 2, Ngaba GP 3, Lunga PK 1, Lohoue PJ 2 1. Faculty of Science, University of Dschang, Cameroon. 2.
More informationTHE PREVALENCE, CLINICAL FEATURES, RISK FACTORS AND OUTCOME ASSOCIATED WITH CRYPTOCOCCAL MENINGITIS IN HIV POSITIVE PATIENTS IN KENYA
December 2010 Ea s t Af r i c a n Me d i c a l Jo u r n a l 481 East African Medical Journal Vol. 87 No. 12 December 2010 THE PREVALENCE, CLINICAL FEATURES, RISK FACTORS AND OUTCOME ASSOCIATED WITH CRYPTOCOCCAL
More informationCryptococcal meningitis and SLE: a diagnostic and therapeutic challenge
CASO CLÍNICO Cryptococcal meningitis and SLE: a diagnostic and therapeutic challenge Khairullah S 1, Sulaiman H 1, Yahya F 1, Jasmin R 1, Cheah TE 1, Sockalingam S 1, Bick J 1, Chin Teck NG 1 ACTA REUMATOL
More informationLOSS OF CONSCIOUSNESS & ASSESSMENT. Sheba Medical Center Acute Medicine Department MATTHEW WRIGHT
LOSS OF CONSCIOUSNESS & ASSESSMENT Sheba Medical Center Acute Medicine Department MATTHEW WRIGHT OUTLINE Causes Head Injury Clinical Features Complications Rapid Assessment Glasgow Coma Scale Classification
More informationCutaneous Cryptococcosis in an Immunocompetent Host
ISSN: 2319-7706 Volume 4 Number 3 (2015) pp. 593-597 http://www.ijcmas.com Original Research Article Cutaneous Cryptococcosis in an Immunocompetent Host Rahul Kamble* Department of Microbiology, T.N.M.C.
More informationReasons why we will never forget. Andrea Antinori INMI L. Spallanzani IRCCS, Roma
Reasons why we will never forget Andrea Antinori INMI L. Spallanzani IRCCS, Roma SMRs according to time spent with CD4 count >500/mm3 after cart initiation in MSM 80,642 HIV-infected individuals eligible
More informationANTIBODIES TO HERPES-SIMPLEX VIRUS IN THE CEREBROSPINAL FLUID OF PATIENTS WITH HER- PETIC ENCEPHALITIS
ANTIBODIES TO HERPES-SIMPLEX VIRUS IN THE CEREBROSPINAL FLUID OF PATIENTS WITH HER- PETIC ENCEPHALITIS F. 0. MACCALLUM, I. J. CHINN AND J. V. T. GOSTLMG Virology Laboratory, Radclife Infirmary, Oxford
More information